Corcept Therapeutics | CORT - Trade Debtors


Corcept Therapeutics reported $39.07M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Ardelyx USD 71.85M 4.76M Dec/2025
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Canopy Growth CAD 140.42M 113.56M Dec/2025
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
Merck USD 11.78B 345M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novartis USD 12.29B 3.3B Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 125.64M 1.57M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026